Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07711522Phase 1Not yet recruiting
Phase 1, randomised trial (2 arms), sponsored by Medipol Mega University Hospital. Primary endpoint: Postoperative Opioid Consumption at 24 hours. Planned start Aug 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07711522.